Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KB003 in Active Rheumatoid Arthritis
NCT00995449Phase 2Terminated
- Sponsor
- Humanigen
- Start
- Jan 2010
- Primary completion
- Mar 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of lenzilumab in rheumatoid arthritis (RA), sponsored by Humanigen. Started Jan 2010; status: terminated.
02
Drugs
lenzilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00995449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00995449.